MedTrace Logo

Local Infiltration With Bupivacaine to Increase Quality of Post-operative Pain Control in Total Knee Replacement

NCT01364194 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2011-06-02

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy of periarticular injection with 0.25% bupivacaine for controlling pain after total knee replacement to improve the quality of post-operative care.

Conditions

  • Pain, Postoperative
  • Arthropathy of Knee Joint

Interventions

DRUG

0.25% Bupivacaine

Periarticular injection with 20 ml of 0.25% bupivacaine before wound closure.

DRUG

0.9% normal saline

Periarticular injection with 20 ml of 0.9% normal saline before wound closure.

Sponsors & Collaborators

  • Siriraj Hospital

    collaborator OTHER

  • Mahidol University

    lead OTHER

Principal Investigators

  • Keerati Chareancholvanich, MD · Siriraj Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2010-09-30
Completion
2010-09-30

Countries

  • Thailand

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01364194 on ClinicalTrials.gov